Photo by lamoune from unsplash
In a series of 8 patients, it was seen that only one patient who had myasthenia and was given HCQ had aggravation of symptoms, and that this aggravation did not… Click to show full abstract
In a series of 8 patients, it was seen that only one patient who had myasthenia and was given HCQ had aggravation of symptoms, and that this aggravation did not respond to withdrawal of the drug.[4] From the literature, it was seen that of 32 patients with myasthenia and SLE, only 3 had been prescribed HCQ and none of them had aggravation of myasthenia. So of these 11 cases, one had aggravation of myasthenic symptoms, which amounts to 9% of cases. So in cases with known myasthenia, it is worthwhile to avoid intake of HCQ for the management of COVID-19.
Keywords:
covid continually;
aggravation;
neurological manifestations;
evolving perplexing;
manifestations covid;
continually evolving
Journal Title: Annals of Indian Academy of Neurology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Annals of Indian Academy of Neurology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!